Joyce S. Plested

4.1k total citations
41 papers, 929 citations indexed

About

Joyce S. Plested is a scholar working on Infectious Diseases, Epidemiology and Microbiology. According to data from OpenAlex, Joyce S. Plested has authored 41 papers receiving a total of 929 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 21 papers in Epidemiology and 15 papers in Microbiology. Recurrent topics in Joyce S. Plested's work include SARS-CoV-2 and COVID-19 Research (19 papers), Bacterial Infections and Vaccines (15 papers) and Pneumonia and Respiratory Infections (13 papers). Joyce S. Plested is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (19 papers), Bacterial Infections and Vaccines (15 papers) and Pneumonia and Respiratory Infections (13 papers). Joyce S. Plested collaborates with scholars based in United Kingdom, United States and Canada. Joyce S. Plested's co-authors include E. Richard Moxon, Katherine Makepeace, Dan M. Granoff, Philip A. Coull, James C. Richards, Andrew D. Cox, J. Claire Wright, Sue M. Paulin, T. S. Wallis and Patricia R. Watson and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Clinical Infectious Diseases.

In The Last Decade

Joyce S. Plested

35 papers receiving 871 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joyce S. Plested United Kingdom	16	425	364	269	245	171	41	929
Francesco Berlanda Scorza Italy	14	298 0.7×	391 1.1×	217 0.8×	327 1.3×	479 2.8×	42	1.2k
Omar Rossi Italy	18	468 1.1×	286 0.8×	170 0.6×	504 2.1×	280 1.6×	59	1.2k
Evgeny A. Semchenko Australia	14	325 0.8×	181 0.5×	75 0.3×	71 0.3×	233 1.4×	30	692
Elisabetta Monaci Italy	13	166 0.4×	437 1.2×	875 3.3×	301 1.2×	408 2.4×	14	1.4k
Pascale Gueirard France	18	576 1.4×	543 1.5×	314 1.2×	131 0.5×	269 1.6×	31	1.4k
Beverlie Baquir United States	12	280 0.7×	225 0.6×	272 1.0×	337 1.4×	338 2.0×	14	981
Sandra Muschiol Sweden	15	303 0.7×	220 0.6×	90 0.3×	156 0.6×	248 1.5×	23	771
Xin‐Xing Gu United States	18	379 0.9×	499 1.4×	116 0.4×	118 0.5×	121 0.7×	33	778
Sarah M. Gilliland United Kingdom	9	193 0.5×	420 1.2×	173 0.6×	141 0.6×	111 0.6×	11	807
Aude Antignac France	14	570 1.3×	558 1.5×	894 3.3×	274 1.1×	487 2.8×	17	1.8k

Countries citing papers authored by Joyce S. Plested

Since Specialization

Citations

This map shows the geographic impact of Joyce S. Plested's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joyce S. Plested with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joyce S. Plested more than expected).

Fields of papers citing papers by Joyce S. Plested

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joyce S. Plested. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joyce S. Plested. The network helps show where Joyce S. Plested may publish in the future.

Co-authorship network of co-authors of Joyce S. Plested

This figure shows the co-authorship network connecting the top 25 collaborators of Joyce S. Plested. A scholar is included among the top collaborators of Joyce S. Plested based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joyce S. Plested. Joyce S. Plested is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kalkeri, Raj, Mingzhu Zhu, Anand Parekh, et al.. (2025). Anti-spike IgG4 and Fc effector responses: The impact of SARS-CoV-2 vaccine platform–specific priming and immune imprinting. Journal of Infection. 91(2). 106543–106543. 1 indexed citations

Áñez, Germán, Wayne Woo, Karen L. Kotloff, et al.. (2025). Safety and immunogenicity of four sequential doses of NVX-CoV2373 in adults and adolescents: A phase 3, randomized, placebo-controlled trial (PREVENT-19). Vaccine. 61. 127362–127362.

Kotloff, Karen L., R. Scott McClelland, Joyce S. Plested, et al.. (2025). Immunogenicity and safety of a monovalent omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose in US adults: interim analysis of a single-arm phase 2/3 study. The Lancet Infectious Diseases. 25(5). 585–594. 5 indexed citations

Plested, Joyce S., Raj Kalkeri, Katherine Clegg Smith, et al.. (2025). Immunogenicity and safety of a monovalent Omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine in previously unvaccinated, SARS-CoV-2 seropositive participants: Primary day-28 analysis of a phase 2/3 open-label study. Vaccine. 55. 127046–127046.

Cai, Zhaohui, Raj Kalkeri, Mingzhu Zhu, et al.. (2024). A Pseudovirus-Based Neutralization Assay for SARS-CoV-2 Variants: A Rapid, Cost-Effective, BSL-2–Based High-Throughput Assay Useful for Vaccine Immunogenicity Evaluation. Microorganisms. 12(3). 501–501. 6 indexed citations

Zhu, Mingzhu, Shane Cloney-Clark, Anand Parekh, et al.. (2023). A Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Immunoglobulin G Assay: A Robust Method for Evaluation of Vaccine Immunogenicity Using an Established Correlate of Protection. Microorganisms. 11(7). 1789–1789. 11 indexed citations

Davis, Matthew, Jeffrey Adelglass, Gordon Chau, et al.. (2023). Immunogenicity and safety of NVX-CoV2373 as a booster: A phase 3 randomized clinical trial in adults. Vaccine. 41(41). 5965–5973. 5 indexed citations

Plested, Joyce S., Gordon Chau, Shane Cloney-Clark, et al.. (2023). Immunogenicity and safety of a fourth homologous dose of NVX-CoV2373. Vaccine. 41(29). 4280–4286. 12 indexed citations

Áñez, Germán, Lisa M. Dunkle, Cynthia L. Gay, et al.. (2022). LB746. Safety and Immunogenicity of a Booster Dose of Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) in Adults from the PREVENT-19 Trial in the United States. Open Forum Infectious Diseases. 9(Supplement_2). 1 indexed citations

10.

Formica, Neil, Raburn M. Mallory, Gary Albert, et al.. (2021). Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial. PLoS Medicine. 18(10). e1003769–e1003769. 64 indexed citations

11.

Shinde, Vivek, Rongman Cai, Joyce S. Plested, et al.. (2020). Induction of Cross-Reactive Hemagglutination Inhibiting Antibody and Polyfunctional CD4+ T-Cell Responses by a Recombinant Matrix-M–Adjuvanted Hemagglutinin Nanoparticle Influenza Vaccine. Clinical Infectious Diseases. 73(11). e4278–e4287. 20 indexed citations

12.

Jäkel, Anne, Joyce S. Plested, Katherine Makepeace, et al.. (2008). Naturally-occurring human serum antibodies to inner core lipopolysaccharide epitopes of Neisseria meningitidis protect against invasive meningococcal disease caused by isolates displaying homologous inner core structures. Vaccine. 26(51). 6655–6663. 20 indexed citations

13.

Plested, Joyce S. & Philip A. Coull. (2003). Opsonophagocytosis Assay Using Flow-Cytometry. Humana Press eBooks. 71. 263–276. 3 indexed citations

14.

Ram, Sanjay, Andrew D. Cox, J. Claire Wright, et al.. (2003). Neisserial Lipooligosaccharide Is a Target for Complement Component C4b. Journal of Biological Chemistry. 278(51). 50853–50862. 81 indexed citations

15.

Cox, Andrew D., J. Claire Wright, M A Gidney, et al.. (2003). Identification of a novel inner‐core oligosaccharide structure in Neisseria meningitidis lipopolysaccharide. European Journal of Biochemistry. 270(8). 1759–1766. 13 indexed citations

16.

Plested, Joyce S., Shannon L. Harris, J. Claire Wright, et al.. (2003). Highly ConservedNeisseria meningitidisInner‐Core Lipopolysaccharide Epitope Confers Protection against Experimental Meningococcal Bacteremia. The Journal of Infectious Diseases. 187(8). 1223–1234. 38 indexed citations

17.

Plested, Joyce S., Philip A. Coull, & M A Gidney. (2003). ELISA. Humana Press eBooks. 71. 243–262. 6 indexed citations

18.

Tang, Christoph M., Dave Stroud, Katherine Makepeace, et al.. (2002). Genetic linkage analysis to identify a gene required for the addition of phosphoethanolamine to meningococcal lipopolysaccharide. Gene. 284(1-2). 133–140. 6 indexed citations

19.

Plested, Joyce S., M A Gidney, Philip A. Coull, et al.. (2000). Enzyme Linked Immunosorbent Assay (ELISA) for the detection of serum antibodies to the inner core lipopolysaccharide of Neisseria meningitidis Group B. Journal of Immunological Methods. 237(1-2). 73–84. 23 indexed citations

20.

Wallis, T. S., Sue M. Paulin, Joyce S. Plested, Patricia R. Watson, & Philip W. Jones. (1995). The Salmonella dublin virulence plasmid mediates systemic but not enteric phases of salmonellosis in cattle. Infection and Immunity. 63(7). 2755–2761. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact